当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析

梅花生物

(600873)

  

流通市值:266.12亿  总市值:266.12亿
流通股本:28.04亿   总股本:28.04亿

梅花生物(600873)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.18亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1641721.04万元,未分配利润1240186.17万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2596866.93万元,负债955145.89万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入5,985,631,650.2824,208,675,106.718,215,447,34512,280,450,603.53
营业总成本5,882,482,412.5621,603,821,463.1415,834,727,996.4210,368,912,543.02
其他经营收益
营业利润139,273,827.892,909,062,330.412,658,930,345.812,096,399,627.92
利润总额154,316,792.713,729,699,988.923,442,504,529.332,089,170,850.25
净利润117,920,964.073,280,879,912.13,025,092,355.051,767,950,116.89
每股收益
其他综合收益-49,472,357.85-104,215,210.75-80,102,163.16-98,666,362.69
综合收益总额68,448,606.223,176,664,701.352,944,990,191.891,669,283,754.2
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计9,819,233,165.29,687,798,652.219,862,310,001.348,841,594,093.26
非流动资产:
非流动资产合计16,149,436,172.9116,228,178,073.1716,129,029,901.7615,159,903,439.87
资产总计25,968,669,338.1125,915,976,725.3825,991,339,903.124,001,497,533.13
流动负债:
流动负债合计7,081,646,179.017,263,114,490.327,646,482,274.566,847,181,423.82
非流动负债:
非流动负债合计2,469,812,717.562,305,291,819.52,229,022,859.092,174,181,395.09
负债合计9,551,458,896.579,568,406,309.829,875,505,133.659,021,362,818.91
所有者权益(或股东权益):
归属于母公司股东权益合计16,417,210,441.5416,347,570,415.5616,115,834,769.4514,980,134,714.22
股东权益合计16,417,210,441.5416,347,570,415.5616,115,834,769.4514,980,134,714.22
负债和股东权益合计25,968,669,338.1125,915,976,725.3825,991,339,903.124,001,497,533.13
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计6,719,761,329.8427,163,735,035.3720,713,725,008.5713,450,929,765.84
经营活动现金流出小计7,875,318,818.3923,154,475,389.1416,002,565,010.2311,138,138,545.21
经营活动产生的现金流量净额-1,155,557,488.554,009,259,646.234,711,159,998.342,312,791,220.63
投资活动产生的现金流量:
投资活动现金流入小计257,351,780.99142,369,783.8569,029,336.3591,637,275.94
投资活动现金流出小计784,256,541.633,286,550,501.893,643,711,406.983,034,934,871.82
投资活动产生的现金流量净额-526,904,760.64-3,144,180,718.04-3,574,682,070.63-2,943,297,595.88
筹资活动产生的现金流量:
筹资活动现金流入小计1,257,639,585.335,935,340,781.924,743,961,248.873,303,480,417.49
筹资活动现金流出小计1,160,628,542.16,942,872,700.165,785,108,571.334,113,628,860.22
筹资活动产生的现金流量净额97,011,043.23-1,007,531,918.24-1,041,147,322.46-810,148,442.73
汇率变动对现金及现金等价物的影响-31,457,118.4317,029,234.725,528,099.831,539,177.23
现金及现金等价物净增加额-1,616,908,324.39-125,423,755.35120,858,705.05-1,409,115,640.75
期末现金及现金等价物余额2,389,527,522.44,006,435,846.794,252,718,307.192,722,743,961.39
补充资料:
现金及现金等价物的净增加额--125,423,755.35--1,409,115,640.75
最新报告期:2026-05-02
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
招商证券周铮,曹承安0.650.831.012026-05-02
国联民生黄楷,张玮航,许隽逸0.670.991.252026-04-27
东方财富证券张志扬,梅宇鑫0.670.840.912026-04-26
长江证券王呈,马太0.770.991.182026-04-26
中金公司侯一林,裘孝锋,贾雄伟0.760.85--2026-04-23
TOP↑